[Title 21 CFR 522.204] [Code of Federal Regulations (annual edition) - April 1, 1996 Edition] [Title 21 - FOOD AND DRUGS] [Chapter I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES--(Continued)] [Subchapter E - ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS] [Part 522 - IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS] [Sec. 522.204 - Boldenone undecylenate injection.] [From the U.S. Government Publishing Office]21 FOOD AND DRUGS 6 1996-04-01 1996-04-01 false Boldenone undecylenate injection. 522.204 Sec. 522.204 FOOD AND DRUGS FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES--(Continued) ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS Sec. 522.204 Boldenone undecylenate injection. (a) Specifications. Each milliliter contains 25 or 50 milligrams of boldenone undecylenate in a sesame oil base. (b) Sponsor. See No. 053501 in Sec. 510.600(c) of this chapter. (c) Conditions of use. (1) It is intended for use as an aid in treating debilitated horses following disease or overwork and overexertion when an improvement in weight, hair coat, or general physical condition is desired. The drug is given only as adjunctive therapy to other specific and supportive therapy for diseases, surgical cases, and traumatic injuries. Optimal results can be expected only when good management and feeding practices are followed. (2) It is administered intramuscularly at a dosage level of 0.5 milligram per pound of body weight. Treatment may be repeated at 3-week intervals. (3) For use in horses only. Do not administer to horses intended for use as food. The effectiveness of the drug in stallions and pregnant mares has not been established, nor has the drug been shown not to be teratogenic in pregnant mares; therefore, this drug should not be used in stallions and pregnant mares. (4) Federal law restricts this drug to use by or on the order of a licensed veterinarian. [40 FR 13858, Mar. 27, 1975, as amended at 50 FR 41489, Oct. 11, 1985]